James P. Allison, PhD, FAACR, Honored With the 2026 AACR Award for Lifetime Achievement in Cancer Research
oncodaily - James P. Allison has been honored with the 2026 AACR Award for Lifetime Achievement in Cancer Research, a distinction recognizing his extraordinary scientific achievements and enduring impact on modern oncology. […]
AI Summary: James P. Allison received the 2026 AACR Award for Lifetime Achievement in Cancer Research for pioneering work in cancer immunotherapy. The award recognizes decades of transformative science that helped establish immune‑checkpoint blockade as a foundational cancer treatment, altering therapeutic strategies across multiple tumor types.
Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61
Related Stories
Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128
Teclistamab outperforms standard regimens in earlier-line relapsed myeloma / 46 hrs
Common asthma drug may overcome immunotherapy resistance in cancers / 11 days
Retifanlimab plus chemotherapy extends survival in advanced squamous anal cancer / 13 days
Zoldonrasib shows durable responses in KRAS G12D lung cancer / 5 wks
Metabolic enzyme linked to immunotherapy benefit; routing metabolites may boost response / 1 month
Atezolizumab plus FOLFOX improves DFS in Stage III dMMR colon cancer / 1 month
AstraZeneca’s in‑vivo CAR‑T yields early responses but raises safety questions / 2 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Alzheimer's disease, Venture Capital, Product Recall, Gene Therapy and look for the RSS link.
StackHealth Time Machine